The pharmacological treatment of neonatal pain

Optimal analgesia remains a major challenge for all involved in the care of (critically) ill newborns. The rapid changes in liver metabolism involving maturation of liver enzymes and renal clearance of drugs render (extreme) very low birth weight infants different from newborns of later postconcepti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in fetal & neonatal medicine 2005-04, Vol.10 (2), p.195-205
Hauptverfasser: Tibboel, D., Anand, K.J.S., van den Anker, J.N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 205
container_issue 2
container_start_page 195
container_title Seminars in fetal & neonatal medicine
container_volume 10
creator Tibboel, D.
Anand, K.J.S.
van den Anker, J.N.
description Optimal analgesia remains a major challenge for all involved in the care of (critically) ill newborns. The rapid changes in liver metabolism involving maturation of liver enzymes and renal clearance of drugs render (extreme) very low birth weight infants different from newborns of later postconceptional age with regards to the use of opioids such as morphine and fentanyl. Acute and/or procedural pain has been investigated fairly recently in randomized controlled trials and there are now guidelines. The long-term effects of opioid use in this particular age group of vulnerable babies await further evaluation.
doi_str_mv 10.1016/j.siny.2004.11.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67418746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1744165X04000812</els_id><sourcerecordid>67418746</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-47158ed998805c34de3695f2e13b5f68f443b995277f0704587843057236af203</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMoVqt_wIP05G3XyeZrF7xI8QsKXip4C2l2YlP2y2Qr9N-b0oI3TzMM77zzzkPIDYWcApX3mzz6bpcXADynNAcoTsgFLVWZQcXlaeoV5xmV4nNCLmPcADBZlnBOJlQooKLkFyRfrnE2rE1oje2b_stb08zGgGZssRtnvZt12HdmTNPB-O6KnDnTRLw-1in5eH5azl-zxfvL2_xxkVmmqjHjKrljXVXpnLCM18hkJVyBlK2Ek6XjnK2qShRKOVDARQrNGQhVMGlcAWxK7g6-Q-i_txhH3fposWlMirONWiqeHuUyCYuD0IY-xoBOD8G3Juw0Bb2npDd6T0nvKWlKdaKUlm6P7ttVi_XfyhFLEjwcBJh-_PEYdLQeO4u1D2hHXff-P_9fFHR2aA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67418746</pqid></control><display><type>article</type><title>The pharmacological treatment of neonatal pain</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tibboel, D. ; Anand, K.J.S. ; van den Anker, J.N.</creator><creatorcontrib>Tibboel, D. ; Anand, K.J.S. ; van den Anker, J.N.</creatorcontrib><description>Optimal analgesia remains a major challenge for all involved in the care of (critically) ill newborns. The rapid changes in liver metabolism involving maturation of liver enzymes and renal clearance of drugs render (extreme) very low birth weight infants different from newborns of later postconceptional age with regards to the use of opioids such as morphine and fentanyl. Acute and/or procedural pain has been investigated fairly recently in randomized controlled trials and there are now guidelines. The long-term effects of opioid use in this particular age group of vulnerable babies await further evaluation.</description><identifier>ISSN: 1744-165X</identifier><identifier>EISSN: 1878-0946</identifier><identifier>DOI: 10.1016/j.siny.2004.11.002</identifier><identifier>PMID: 15701584</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Analgesics, Opioid - pharmacology ; Assessment ; Drug Administration Routes ; Fentanyl ; Genetics ; Humans ; Infant, Newborn ; Morphine ; Opioids ; Pain ; Pain - drug therapy ; Pharmacodynamics ; Polymorphisms</subject><ispartof>Seminars in fetal &amp; neonatal medicine, 2005-04, Vol.10 (2), p.195-205</ispartof><rights>2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-47158ed998805c34de3695f2e13b5f68f443b995277f0704587843057236af203</citedby><cites>FETCH-LOGICAL-c379t-47158ed998805c34de3695f2e13b5f68f443b995277f0704587843057236af203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1744165X04000812$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15701584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tibboel, D.</creatorcontrib><creatorcontrib>Anand, K.J.S.</creatorcontrib><creatorcontrib>van den Anker, J.N.</creatorcontrib><title>The pharmacological treatment of neonatal pain</title><title>Seminars in fetal &amp; neonatal medicine</title><addtitle>Semin Fetal Neonatal Med</addtitle><description>Optimal analgesia remains a major challenge for all involved in the care of (critically) ill newborns. The rapid changes in liver metabolism involving maturation of liver enzymes and renal clearance of drugs render (extreme) very low birth weight infants different from newborns of later postconceptional age with regards to the use of opioids such as morphine and fentanyl. Acute and/or procedural pain has been investigated fairly recently in randomized controlled trials and there are now guidelines. The long-term effects of opioid use in this particular age group of vulnerable babies await further evaluation.</description><subject>Analgesics, Opioid - pharmacology</subject><subject>Assessment</subject><subject>Drug Administration Routes</subject><subject>Fentanyl</subject><subject>Genetics</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Morphine</subject><subject>Opioids</subject><subject>Pain</subject><subject>Pain - drug therapy</subject><subject>Pharmacodynamics</subject><subject>Polymorphisms</subject><issn>1744-165X</issn><issn>1878-0946</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMoVqt_wIP05G3XyeZrF7xI8QsKXip4C2l2YlP2y2Qr9N-b0oI3TzMM77zzzkPIDYWcApX3mzz6bpcXADynNAcoTsgFLVWZQcXlaeoV5xmV4nNCLmPcADBZlnBOJlQooKLkFyRfrnE2rE1oje2b_stb08zGgGZssRtnvZt12HdmTNPB-O6KnDnTRLw-1in5eH5azl-zxfvL2_xxkVmmqjHjKrljXVXpnLCM18hkJVyBlK2Ek6XjnK2qShRKOVDARQrNGQhVMGlcAWxK7g6-Q-i_txhH3fposWlMirONWiqeHuUyCYuD0IY-xoBOD8G3Juw0Bb2npDd6T0nvKWlKdaKUlm6P7ttVi_XfyhFLEjwcBJh-_PEYdLQeO4u1D2hHXff-P_9fFHR2aA</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Tibboel, D.</creator><creator>Anand, K.J.S.</creator><creator>van den Anker, J.N.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>The pharmacological treatment of neonatal pain</title><author>Tibboel, D. ; Anand, K.J.S. ; van den Anker, J.N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-47158ed998805c34de3695f2e13b5f68f443b995277f0704587843057236af203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Analgesics, Opioid - pharmacology</topic><topic>Assessment</topic><topic>Drug Administration Routes</topic><topic>Fentanyl</topic><topic>Genetics</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Morphine</topic><topic>Opioids</topic><topic>Pain</topic><topic>Pain - drug therapy</topic><topic>Pharmacodynamics</topic><topic>Polymorphisms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tibboel, D.</creatorcontrib><creatorcontrib>Anand, K.J.S.</creatorcontrib><creatorcontrib>van den Anker, J.N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in fetal &amp; neonatal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tibboel, D.</au><au>Anand, K.J.S.</au><au>van den Anker, J.N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The pharmacological treatment of neonatal pain</atitle><jtitle>Seminars in fetal &amp; neonatal medicine</jtitle><addtitle>Semin Fetal Neonatal Med</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>10</volume><issue>2</issue><spage>195</spage><epage>205</epage><pages>195-205</pages><issn>1744-165X</issn><eissn>1878-0946</eissn><abstract>Optimal analgesia remains a major challenge for all involved in the care of (critically) ill newborns. The rapid changes in liver metabolism involving maturation of liver enzymes and renal clearance of drugs render (extreme) very low birth weight infants different from newborns of later postconceptional age with regards to the use of opioids such as morphine and fentanyl. Acute and/or procedural pain has been investigated fairly recently in randomized controlled trials and there are now guidelines. The long-term effects of opioid use in this particular age group of vulnerable babies await further evaluation.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>15701584</pmid><doi>10.1016/j.siny.2004.11.002</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1744-165X
ispartof Seminars in fetal & neonatal medicine, 2005-04, Vol.10 (2), p.195-205
issn 1744-165X
1878-0946
language eng
recordid cdi_proquest_miscellaneous_67418746
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analgesics, Opioid - pharmacology
Assessment
Drug Administration Routes
Fentanyl
Genetics
Humans
Infant, Newborn
Morphine
Opioids
Pain
Pain - drug therapy
Pharmacodynamics
Polymorphisms
title The pharmacological treatment of neonatal pain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A22%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20pharmacological%20treatment%20of%20neonatal%20pain&rft.jtitle=Seminars%20in%20fetal%20&%20neonatal%20medicine&rft.au=Tibboel,%20D.&rft.date=2005-04-01&rft.volume=10&rft.issue=2&rft.spage=195&rft.epage=205&rft.pages=195-205&rft.issn=1744-165X&rft.eissn=1878-0946&rft_id=info:doi/10.1016/j.siny.2004.11.002&rft_dat=%3Cproquest_cross%3E67418746%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67418746&rft_id=info:pmid/15701584&rft_els_id=S1744165X04000812&rfr_iscdi=true